---
source_image: "legal-filing+court-document+affidavit+deposition-transcript__EFTA01377823_20260130_p001_i001.png"
source_pdf: "EFTA01377823.pdf"
method: pdf_text
words: 573
confidence: 1.00
extracted: 2026-02-13T17:07:23.543411
---

ti- /A 
such persons against certain liabilities. 
These indemnification provisions and the indemnification agreements entered into between the Registrant and its officers and 
directors may be sufficiently broad to permit indemnification of the Registrant's officers and directors for liabilities (including 
reimbursement of expenses incurred) arising under the Securities Act of 1933, as amended (Securities Act). 
The underwriting agreement filed as Exhibit 1.1 to this registration statement provides for indemnification by the underwriters 
of the Registrant and its officers and directors for certain liabilities arising under the Securities Act and otherwise. 
Item 15. Recent Sales of Unregistered Securities. 
Common Stock Issuances 
In July 2015, the Registrant sold 3,777 shares of its common stock, in consideration for services previously rendered by a 
deceased employee, to a beneficiary of the employee, at a purchase price of approximately $0.01 per share, for an aggregate 
purchase price of approximately $37.77. 
Preferred Stock Issuances 
From July 2012 through September 2012, the Registrant sold an aggregate of 20,164.210 shares of its Series D convertible 
preferred stock to 21 accredited investors at a purchase price of approximately $11.014 per share, for an aggregate purchase price 
of approximately $222.1 million. 
From September 2014 through October 2015; the Registrant sold an aggregate of 11,640,347 shares of its Series E 
convertible preferred stock to 12 accredited investors at a purchase price of approximately $15.46345 per share, for an aggregate 
purchase price of approximately $180.0 million. 
Option and RSU Issuances 
Since June 1, 2012, the Registrant granted to its directors, officers, employees, consultants, and other service providers 
options to purchase an aggregate of 119,745,206 shares of its common stock under its equity compensation plans at exercise 
prices ranging from approximately $2.728 to $15.39 per share. 
Since June 1, 2012, the Registrant granted to its directors, officers, employees, consultants, and other service providers an 
aggregate of 1,025,000 restricted stock units to be settled in shares of its common stock under its equity compensation plans. 
11-2 
Toil* of Contents 
Wanants 
Since June 1, 2012, the Registrant issued to one accredited investor warrants to purchase an aggregate of 15,761.570 
shares of its common stock at exercise prices ranging from $11.01 to $14.37 per share, for an aggregate purchase price of 
approximately $194.7 million. 
Shares Issued in Connection with Acquisitions 
Since June 1, 2012, the Registrant issued an aggregate of 12,157.347 shares of its common stock in connection with 
acquisitions of certain companies or their assets and as consideration to individuals and entities who were former service providers 
and/or stockholders of such companies. In connection with the Registrant's acquisitions of four companies, the Registrant issued 
shares to 3, 11, 27, and 12 individuals or entities, respectively. In each of these transactions recipients of shares represented to the 
Registrant that they are "accredited investors: as defined in Regulation D promulgated under Section 4(a)(2) of the Securities Act, 
formerly Section 4(2), or that they have appointed a purchaser representative (as defined in Rule 501(h)). In connection with the 
Registrant's acquisitions of certain assets, the Registrant issued shares to one entity in each instance. The Registrant believes that 
each recipient of shares was sophisticated and capable of understanding and evaluating the risks of acquiring the Registrant's 
securities. 
None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering. 
http://www. sec. g ov/A rehi vestedgar/data/1512673AMS 11193125 I 5369092/d937622ds I a. htm[11/6/2015 7:37:12 A M j 
CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) 
CONFIDENTIAL 
DB-SDNY-0074975 
SDNY_GM_00221159 
EFTA01377823
